{"id":130265,"date":"2025-08-12T07:04:42","date_gmt":"2025-08-12T15:04:42","guid":{"rendered":"https:\/\/xira.com\/p\/2025\/08\/12\/biontech-to-pay-curevac-gsk-740m-plus-royalties-to-settle-mrna-patent-disputes\/"},"modified":"2025-08-12T07:04:42","modified_gmt":"2025-08-12T15:04:42","slug":"biontech-to-pay-curevac-gsk-740m-plus-royalties-to-settle-mrna-patent-disputes","status":"publish","type":"post","link":"https:\/\/xira.com\/p\/2025\/08\/12\/biontech-to-pay-curevac-gsk-740m-plus-royalties-to-settle-mrna-patent-disputes\/","title":{"rendered":"BioNTech To Pay CureVac, GSK $740M Plus Royalties To Settle mRNA Patent Disputes"},"content":{"rendered":"<p>The post <a href=\"https:\/\/medcitynews.com\/2025\/08\/biontech-curevac-mrna-vaccine-patent-settlement-gsk-pfizer-bntx-cvac-gsk-pfe\/\" rel=\"nofollow noopener\" target=\"_blank\">BioNTech To Pay CureVac, GSK $740M Plus Royalties To Settle mRNA Patent Disputes<\/a> appeared first on <a href=\"https:\/\/abovethelaw.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Above the Law<\/a>.<\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2025\/08\/biontech-curevac-mrna-vaccine-patent-settlement-gsk-pfizer-bntx-cvac-gsk-pfe\/\" rel=\"nofollow noopener\" target=\"_blank\">BioNTech To Pay CureVac, GSK $740M Plus Royalties To Settle mRNA Patent Disputes<\/a> appeared first on <a href=\"https:\/\/abovethelaw.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Above the Law<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The post BioNTech To Pay CureVac, GSK $740M Plus Royalties To Settle mRNA Patent Disputes appeared first on Above the Law. The post BioNTech To Pay CureVac, GSK $740M Plus Royalties To Settle mRNA Patent Disputes appeared first on Above the Law.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[16],"tags":[],"class_list":["post-130265","post","type-post","status-publish","format-standard","hentry","category-above_the_law"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/130265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/comments?post=130265"}],"version-history":[{"count":0,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/130265\/revisions"}],"wp:attachment":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media?parent=130265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/categories?post=130265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/tags?post=130265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}